(a) HepG2 cells were treated with various concentrations of human recombinant BMP4 (0, 25, 50, 100 and 150 ng/mL) for different lengths of time to assay the effects on HCC cells proliferation. The gene discussed is BMP4; the disease is hepatocellular carcinoma.